Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G HALE

Showing results (261-270 of 354) with videos related to

Pageof 36
Sort By:
The Journal of Arthroplasty|May 29, 2025
Association Between Mental Health Conditions and Revision Rates in Patients Undergoing Total Hip and Knee Arthroplasty: A Systematic Review and Meta-AnalysisAriella J Smith, David A M Chang, Teresa Neeman, et al.
Lancet (London, England)|July 30, 1994
Preliminary evidence from magnetic resonance imaging for reduction in disease activity after lymphocyte depletion in multiple sclerosisT Moreau, J Thorpe, D Miller, et al.
Journal of Virology|August 7, 2015
Novel Bat Influenza Virus NS1 Proteins Bind Double-Stranded RNA and Antagonize Host Innate ImmunityHannah L Turkington, Mindaugas Juozapaitis, Philip S Kerry, et al.
Arthritis and Rheumatism|October 11, 2001
Morbidity and mortality in rheumatoid arthritis patients with prolonged and profound therapy-induced lymphopeniaJ D Isaacs, S Greer, S Sharma, et al.
British Journal of Haematology|October 16, 1999
The PNH phenotype cells that emerge in most patients after CAMPATH-1H therapy are present prior to treatmentA C Rawstron, S J Rollinson, S Richards, et al.
The British Journal of Ophthalmology|November 1, 1995
Monoclonal antibody therapy of chronic intraocular inflammation using Campath-1HJ D Isaacs, G Hale, H Waldmann, et al.
Blood|December 9, 1998
Improving the outcome of bone marrow transplantation by using CD52 monoclonal antibodies to prevent graft-versus-host disease and graft rejectionG Hale, M J Zhang, D Bunjes, et al.
Lancet (London, England)|October 21, 1989
Effect of graft perfusion with two CD45 monoclonal antibodies on incidence of kidney allograft rejectionY Brewer, A Palmer, D Taube, et al.
The Journal of Clinical Investigation|December 15, 1996
Mechanism of first-dose cytokine-release syndrome by CAMPATH 1-H: involvement of CD16 (FcgammaRIII) and CD11a/CD18 (LFA-1) on NK cellsM G Wing, T Moreau, J Greenwood, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|April 20, 2000
Tissue disposition and pharmacokinetics of recombinant human nerve growth factor after acute and chronic subcutaneous administration in monkeysC B Nguyen, L Harris, E Szönyi, et al.
Pageof 36

Showing results (261-270 of 354) with videos related to

Sort By:
Pageof 36
The Journal of Arthroplasty|May 29, 2025
Association Between Mental Health Conditions and Revision Rates in Patients Undergoing Total Hip and Knee Arthroplasty: A Systematic Review and Meta-AnalysisAriella J Smith, David A M Chang, Teresa Neeman, et al.
Lancet (London, England)|July 30, 1994
Preliminary evidence from magnetic resonance imaging for reduction in disease activity after lymphocyte depletion in multiple sclerosisT Moreau, J Thorpe, D Miller, et al.
Journal of Virology|August 7, 2015
Novel Bat Influenza Virus NS1 Proteins Bind Double-Stranded RNA and Antagonize Host Innate ImmunityHannah L Turkington, Mindaugas Juozapaitis, Philip S Kerry, et al.
Arthritis and Rheumatism|October 11, 2001
Morbidity and mortality in rheumatoid arthritis patients with prolonged and profound therapy-induced lymphopeniaJ D Isaacs, S Greer, S Sharma, et al.
British Journal of Haematology|October 16, 1999
The PNH phenotype cells that emerge in most patients after CAMPATH-1H therapy are present prior to treatmentA C Rawstron, S J Rollinson, S Richards, et al.
The British Journal of Ophthalmology|November 1, 1995
Monoclonal antibody therapy of chronic intraocular inflammation using Campath-1HJ D Isaacs, G Hale, H Waldmann, et al.
Blood|December 9, 1998
Improving the outcome of bone marrow transplantation by using CD52 monoclonal antibodies to prevent graft-versus-host disease and graft rejectionG Hale, M J Zhang, D Bunjes, et al.
Lancet (London, England)|October 21, 1989
Effect of graft perfusion with two CD45 monoclonal antibodies on incidence of kidney allograft rejectionY Brewer, A Palmer, D Taube, et al.
The Journal of Clinical Investigation|December 15, 1996
Mechanism of first-dose cytokine-release syndrome by CAMPATH 1-H: involvement of CD16 (FcgammaRIII) and CD11a/CD18 (LFA-1) on NK cellsM G Wing, T Moreau, J Greenwood, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|April 20, 2000
Tissue disposition and pharmacokinetics of recombinant human nerve growth factor after acute and chronic subcutaneous administration in monkeysC B Nguyen, L Harris, E Szönyi, et al.
Pageof 36